药物对比
Dapagliflozin vs Rosiglitazone
比较 Dapagliflozin（Farxiga）与 Rosiglitazone 治疗2型糖尿病。心脏获益、肾脏保护、副作用及用法方面的差异。
此页面暂无可用的对比维度。
临床背景
This comparison arises when choosing an add-on oral agent for type 2 diabetes patients with cardiovascular risk or heart failure concerns.
结论
Dapagliflozin is typically favored over rosiglitazone for most patients due to organ-protective effects, though selection must be individualized.
全部药物对比